AstraZeneca’s senior vice-president and head of precision medicine, research & development, Ruth March, has been central to the company’s transformed approach to personalised treatment.
Horizon Pharma's executive vice president, head of research and development, and chief scientific officer talks to pharmaphorum about what inspires her in life sciences,
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
